Literature DB >> 10947972

Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8.

H R Stennicke1, M Renatus, M Meldal, G S Salvesen.   

Abstract

Subsite interactions are considered to define the stringent specificity of proteases for their natural substrates. To probe this issue in the proteolytic pathways leading to apoptosis we have examined the P(4), P(1) and P(1)' subsite preferences of human caspases 1, 3, 6, 7 and 8, using internally quenched fluorescent peptide substrates containing o-aminobenzoyl (also known as anthranilic acid) and 3-nitro-tyrosine. Previous work has demonstrated the importance of the S(4) subsite in directing specificity within the caspase family. Here we demonstrate the influence of the S(1) and S(1)' subsites that flank the scissile peptide bond. The S(1) subsite, the major specificity-determining site of the caspases, demonstrates tremendous selectivity, with a 20000-fold preference for cleaving substrates containing aspartic acid over glutamic acid at this position. Thus caspases are among the most selective of known endopeptidases. We find that the caspases show an unexpected degree of discrimination in the P(1)' position, with a general preference for small amino acid residues such as alanine, glycine and serine, with glycine being the preferred substituent. Large aromatic residues are also surprisingly well-tolerated, but charged residues are prohibited. While this describes the general order of P(1)' subsite preferences within the caspase family, there are some differences in individual profiles, with caspase-3 being particularly promiscuous. Overall, the subsite preferences can be used to predict natural substrates, but in certain cases the cleavage site within a presumed natural substrate cannot be predicted by looking for the preferred peptide cleavage sites. In the latter case we conclude that second-site interactions may overcome otherwise sub-optimal cleavage sequences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947972      PMCID: PMC1221285     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

Authors:  H Blanchard; L Kodandapani; P R Mittl; S D Marco; J F Krebs; J C Wu; K J Tomaselli; M G Grütter
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

2.  Caspases: preparation and characterization.

Authors:  H R Stennicke; G S Salvesen
Journal:  Methods       Date:  1999-04       Impact factor: 3.608

3.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

4.  Characterization of the S1 binding site of the glutamic acid-specific protease from Streptomyces griseus.

Authors:  H R Stennicke; J J Birktoft; K Breddam
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

5.  Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries.

Authors:  M M Smith; L Shi; M Navre
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

6.  Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.

Authors:  M Germain; E B Affar; D D'Amours; V M Dixit; G S Salvesen; G G Poirier
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

7.  Caspase-9 can be activated without proteolytic processing.

Authors:  H R Stennicke; Q L Deveraux; E W Humke; J C Reed; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

8.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

9.  Substrate specificities of caspase family proteases.

Authors:  R V Talanian; C Quinlan; S Trautz; M C Hackett; J A Mankovich; D Banach; T Ghayur; K D Brady; W W Wong
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

10.  In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells.

Authors:  M M Simon; M Hausmann; T Tran; K Ebnet; J Tschopp; R ThaHla; A Müllbacher
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  109 in total

1.  Inhibition of distant caspase homologues by natural caspase inhibitors.

Authors:  S J Snipas; H R Stennicke; S Riedl; J Potempa; J Travis; A J Barrett; G S Salvesen
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Effect of caspase cleavage-site phosphorylation on proteolysis.

Authors:  József Tözsér; Péter Bagossi; Gábor Zahuczky; Suzanne I Specht; Eva Majerova; Terry D Copeland
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 3.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

4.  A quantitative proteomics design for systematic identification of protease cleavage events.

Authors:  Francis Impens; Niklaas Colaert; Kenny Helsens; Bart Ghesquière; Evy Timmerman; Pieter-Jan De Bock; Benjamin M Chain; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

5.  Characterization of Puma-dependent and Puma-independent neuronal cell death pathways following prolonged proteasomal inhibition.

Authors:  Liam P Tuffy; Caoimhín G Concannon; Beatrice D'Orsi; Matthew A King; Ina Woods; Heinrich J Huber; Manus W Ward; Jochen H M Prehn
Journal:  Mol Cell Biol       Date:  2010-10-04       Impact factor: 4.272

6.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

Review 7.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

8.  Systems analysis of cancer cell heterogeneity in caspase-dependent apoptosis subsequent to mitochondrial outer membrane permeabilization.

Authors:  Jasmin Schmid; Heiko Dussmann; Gerhardt J Boukes; Lorna Flanagan; Andreas U Lindner; Carla L O'Connor; Markus Rehm; Jochen H M Prehn; Heinrich J Huber
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 9.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

10.  A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3.

Authors:  Aditya Murthy; Yun Li; Ivan Peng; Mike Reichelt; Anand Kumar Katakam; Rajkumar Noubade; Merone Roose-Girma; Jason DeVoss; Lauri Diehl; Robert R Graham; Menno van Lookeren Campagne
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.